tradingkey.logo

ESSA Pharma Inc <EPIX.OQ> expected to post a loss of 17 cents a share - Earnings Preview

ReutersMay 9, 2025 3:42 PM
  • ESSA Pharma Inc EPIX.OQ EPIX.O is expected to report results on August 4 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for ESSA Pharma Inc is for a loss of 17 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 65.2% in the last three months. ​

  • Wall Street's median 12-month price target for ESSA Pharma Inc is $1.70​, below​ its last closing price of $1.71. ​​​

This summary was machine generated May 9 at 15:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI